
Population-based BRCA genetic testing for women aged 30 and older could prevent over 2,000 breast cancers and 485 ovarian cancers in Canada, but faces challenges in achieving high uptake and building necessary testing infrastructure.


coremsg

In a Markov model, testing all women in Canada for BRCA1 and 2 genetic mutations was cost-effective, compared with testing only women with a family history of breast cancer.

Is Population-Based BRCA Testing Cost-Effective?

population-based-brca-testing-could-prevent-thousands-of-breast-and-ovarian-cancers-but-faces-challenges-in-implementation


Population-Based BRCA Testing Could Prevent Thousands of Breast and Ovarian Cancers, but Faces Challenges in Implementation
